Health Care · Immunology & Inflammation Therapeutics
Egle Therapeutics: Products & infrastructure
Egle Therapeutics has 1 clinical trials on record, 1 under way.
Data updated Nov 21, 2026 · Back to the company report
Products
Egle Therapeutics has 1 clinical trials on record, 1 under way.
1clinical trials
1trials under way
2EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy vo…
Human Pharmacology (Phase I)- First administration to humans · Atopic dermatitis · Germany, Bulgaria, Poland
Oct 2025
First-in-human Phase 1/2 Trial of EGL-001 in Adult Patients with Selected Advanced and/or Metastatic Solid Tumors (Prot…
Human Pharmacology (Phase I)- First administration to humans · Advanced and/or Metastatic Solid Tumors · Spain, France
Sep 2024
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
phase 2 · under way · 50 participants · Solid Tumor, Adult
Sep 2024
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
